New Women’s Health Focus Could Be $350B Market?!

(VitalNews.org) – Many have recently discussed how menopause could present a gap in the market that companies could fill to make a huge difference in women’s health.

Celebrities like Drew Barrymore and Naomi Watts have spoken about their personal experiences when dealing with menopause and even promoted products to help. However, when it comes to menopause, there really aren’t many products out there to begin with; this is a gap that companies could fill in the market.

According to a recent McKinsey report, menopause has the highest unmet need and it has an “enormous potential for innovative treatments.” It projects that the market could be up to $350b.

Menopause is when a woman stops having her menstrual cycle for at least twelve consecutive months. Women typically get this around age 51, but some women can get it later or earlier. Perimenopause is also when a woman gets menopausal symptoms for years beforehand.

Some symptoms that a woman might experience include anxiety, weight gain, hot flashes, vaginal dryness, mood swings, and changes in skin. A lot of these can be treated with hormone-balancing treatments.

Hormone therapy was a popular treatment years ago until it was accused of being linked to breast cancer and heart disease. However, some hormone therapy medications still exist, such as ones made by Pfizer.

There are many different products that are hormone-based and products that are geared towards helping with hot flashes, sleep, or other symptoms that come with menopause. Although these companies have some options, the market is very small for women’s health and even smaller in the menopause category.

Leerink Partners’ Sasha Kelemen, who heads women’s health investment banking, said “Menopause is inevitable, like death and taxes, and all women will go through this. We just don’t have a lot of public women’s health companies yet, and hopefully, that will change.”

Copyright 2024, VitalNews.org